alexion pharmaceuticals inc
Leonard Bell M.D.
Co-Founder, Chairman of the Board and Chief Executive Officer, Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Leonard Bell, M.D., Co-Founded Alexion Pharmaceuticals, Inc. and has been its Chief Executive Officer since January 1992 and Chairman of the Board since October 2014. Dr. Bell served as Secretary of Alexion Pharmaceuticals, Inc. since 1992 and as its Treasurer since January 1992. From January 1992 to March 2002, Dr. Bell also served as the President of Alexion Pharmaceuticals, Inc. He has been a Director of Alexion Pharmaceuticals, Inc., since February 1992. He serves ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*
Co-Founder, Chairman of the Board and Chief Executive Officer
Yale University School Of Medicine
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Stephen Foots||Chief Executive Officer, Executive Director, Chairman of Group Executive Committee, Member of Risk Management Committee, Member of Routine Business Committee, Member of Nomination Committee, Member of Finance Committee and Member of Group Safety, Health & Environment Steering Committee|
Croda International plc
|Heinz-Jürgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2013.|